Boston Scientific Corporation (BSX) is a developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. The Healthcare sector has certainly been full of mergers, acquisitions and potential inversions. Boston Scientific has earned a SELL WATCH classification with the recent rapid move to the upside reaching 140.3% FV. This places the company at 480 out of 500 stocks in the S&P500 Index. The stock became overvalued when it passed through $20.31 and moved up to $21.92. There may remain more movement to the upside, but the probability is getting lower as it moves further upward.
Boston Scientific Corporation (BSX) – Moves to “Sell/Watch” classification
About the Author: Guest Contributor
Articles attributed to "Guest Contributor" are written by former employees or invited guests. Contents are for your consideration only The opinions expressed herein are those of the authors and do not necessarily represent the views of Charter Trust Company. Nothing contained in this communication should be construed as investment advice.